Rika Kizawa
Ariake, 1358550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: July 02, 2026
ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.
Journal: Cancer research communications
Published: December 17, 2025
Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: September 13, 2025
Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.
Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.
Journal: Discover oncology
Published: July 24, 2025
IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.
Journal: Journal of translational medicine
Published: July 01, 2025
The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 10, 2025
National Cancer Control in a Super-Aged Society-Based on the Fourth Basic Plan to Promote Cancer Control
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: March 12, 2025
Molecular and Biological Features of Invasive Lobular Carcinoma: Toward New Treatment Strategies.
Journal: Annals of surgical oncology
Published: March 06, 2025
"Attenuated" Pulmonary Tumor Thrombotic Microangiopathy on Anti-Vascular Endothelial Growth Factor Treatment: A Case Report.
Journal: Case reports in oncology
Published: November 24, 2024
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study).
Journal: Journal for immunotherapy of cancer
Published: October 20, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Journal: Breast cancer (Tokyo, Japan)
Published: September 17, 2024
Artificial intelligence system for predicting hand-foot skin reaction induced by vascular endothelial growth factor receptor inhibitors.
Journal: Scientific reports
Published: May 20, 2024
Last Updated: 09/26/2026